NEW YORK, May 3 (GenomeWeb News) - BD Diagnostics, a segment of Becton Dickinson, has acquired the technology and other assets of FFE Weber, a German company that specializes in the separation and fractionation of complex proteins.
Located near the Max-Planck Institute in Munich, FFE Weber manufactures and sells the Free Flow Electrophoresis protein-separation system. The technology enables a pre-analytical protein separation step "that, when used in combination with high performance liquid chromatography, 2D-gel and mass spectrometry-based protein analytical procedures, allows deeper interrogation into the plasma proteome than is possible with current methodologies," BD said in a statement.
The acquisition "represents an important step in BD's strategy to invest in emerging technologies which position the company in areas that hold promise for new diagnostic methods, such as the evolution of protein biomarker research into the clinical diagnostic lab of the future," Edward Ludwig, BD chairman, President and CEO, said in the statement.
Gerhard Weber, who founded FFE Weber and has functioned as owner and lead inventor for "many years," will "work closely" with BD after the sale.
The financial terms were not disclosed, though BD said they "are not material" to the company.